Toxins from anaerobic bacteria: specificity and molecular mechanisms of action

被引:41
作者
Boquet, P [1 ]
Munro, P
Fiorentini, C
Just, I
机构
[1] Fac Med Nice, INSERM, Unit 452, F-06107 Nice 2, France
[2] Ist Super Sanita, Dept Ultrastruct, I-00161 Rome, Italy
[3] Inst Pharmakol & Toxikol, D-79104 Freiburg, Germany
关键词
D O I
10.1016/S1369-5274(98)80144-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Major advances have been made in the past five years in the identification of cellular targets of toxins produced by anaerobic bacteria. These targets include the vesicular membrane docking and fusion apparatus, the actin cytoskeleton, the signal transduction machinery and the cell membrane. The recent discovery that large clostridial toxins (Clostridium difficile A and B toxins, C. sordellii lethal and hemorrhagic toxins, and alpha C. novyi toxin) are monoglucosyltransferases, together with the establishment of the perfringolysin crystal structure, has led to new insights in the field of toxins from anaerobic bacteria.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 47 条
[1]   MONOGLUCOSYLATION OF LOW-MOLECULAR-MASS GTP-BINDING RHO PROTEINS BY CLOSTRIDIAL CYTOTOXINS [J].
AKTORIES, K ;
JUST, I .
TRENDS IN CELL BIOLOGY, 1995, 5 (12) :441-443
[2]  
Aktories K, 1997, ADV EXP MED BIOL, V419, P53
[3]   Rho proteins: Targets for bacterial toxins [J].
Aktories, K .
TRENDS IN MICROBIOLOGY, 1997, 5 (07) :282-288
[4]  
AKTORIES K, 1997, BACTERIAL TOXINS TOO, P93
[5]  
Aktories K, 1997, BACTERIAL TOXINS TOO, P61
[6]  
Ashton AC, 1997, J NEUROCHEM, V68, P649
[7]   THE PRIMARY STRUCTURE OF CLOSTRIDIUM-SEPTICUM ALPHA-TOXIN EXHIBITS SIMILARITY WITH THAT OF AEROMONAS-HYDROPHILA AEROLYSIN [J].
BALLARD, J ;
CRABTREE, J ;
ROE, BA ;
TWETEN, RK .
INFECTION AND IMMUNITY, 1995, 63 (01) :340-344
[8]   Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: Prototypes of pore-forming bacterial cytolysins [J].
Bhakdi, S ;
Bayley, H ;
Valeva, A ;
Walev, I ;
Walker, B ;
Weller, U ;
Kehoe, M ;
Palmer, M .
ARCHIVES OF MICROBIOLOGY, 1996, 165 (02) :73-79
[9]  
BOQUET P, 1995, METHOD ENZYMOL, V256, P297
[10]   Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].
Borodic, G ;
Johnson, E ;
Goodnough, M ;
Schantz, E .
NEUROLOGY, 1996, 46 (01) :26-29